Zeitschrift für Palliativmedizin 2007; 8(4): 143-154
DOI: 10.1055/s-2007-986254
CME-Fortbildung

© Georg Thieme Verlag KG Stuttgart · New York

Diagnostik und Therapie der Atemnot in der Palliativmedizin

Diagnostics and Therapy of Dyspnoea in Palliative MedicineK.  E.  Clemens, E.  Klaschik
Further Information

Publication History

Publication Date:
11 December 2007 (online)

Abstract

Respiratory symptoms, such as tussis, haemoptysis, pleural effusion and dyspnoea, are common in palliative care patients and tend to increase as the underlying disease advances. Compared to the other symptoms, dyspnoea is of different nature, insofar as it is a subjective symptom where only the patient himself is in a position to judge its severity. It is not self-evident that measurable pathophysiological changes are to be found. Profound knowledge of physiology and pathophysiology is indispensable for targeted diagnostics and rational therapy. Key strategies of treatment include measures that will reduce increased breathing effort and respiratory rate, improve CO2 elimination and have a positive impact on the distressing and emotional response to the experience of air hunger.

Literatur

  • 1 Gugger M, Bachofen H. Dyspnoe, Grundlagen und Pathophysiologie.  Schweiz Med Forum. 2001;  Nr. 6
  • 2 Pfreundschuh M, Schölmerich J. Pathophysiologie/Pathobiochemie. München; Urban & Fischer 2000: 187-206
  • 3 Thews G. Lungenatmung. In: Schmidt RF, Thews G (Hrsg) Physiologie des Menschen. 24. Aufl. Berlin; Springer 1990: 574-609
  • 4 Thews G. Lungenatmung. In: Schmidt RF, Thews G (Hrsg) Physiologie des Menschen. 27. Aufl. Berlin; Springer 1997: 565-603
  • 5 Moosavi S H, Golestanian E, Binks A P. et al . Hypoxic and hypercapnic drives to breathe generate equivalent levels of air hunger in humans.  J Appl Physiol. 2003;  94 141-154
  • 6 Thews G. Lungenatmung. In: Schmidt RF, Thews G (Hrsg) Physiologie des Menschen. 17. Aufl. Berlin; Springer 1976: 452-486
  • 7 Zander R. Sauerstoff von A-Z: Von der Alveole bis zur Zelle. Refresher Course. Aktuelles Wissen für Anästhesisten. Herausgegeben von der Deutschen Akademie für Anästhesiologische Fortbildung, Nürnberg. Juni 2002 Nr. 28
  • 8 Clemens K E, Klaschik E. Respiratorische Symptome. In: Aulbert E, Nauck F, Radbruch L (Hrsg) Lehrbuch der Palliativmedizin. 2. Aufl. Stuttgart; Schattauer 2007: 375-393
  • 9 Manning H L, Schratzenstein R M. Pathophysiology of Dyspnea. Review.  N Engl J Med. 1995;  333 1547-1553
  • 10 Bruera E, Sweeney K, Willey J. et al . A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea.  Palliat Med. 2003;  17 659-663
  • 11 Ventafridda V. Palliative Care: A new reality in medicine.  Rec Res Cancer Res. 1991;  121 393-398
  • 12 Bausewein C, Farquhar M, Booth S. et al . Measurement of breathlessness in advanced disease: a systematic review.  Respir Med. 2007;  101 399-410
  • 13 Klaschik E. Schmerztherapie und Symptomkontrolle in der Palliativmedizin. In: Husebö S, Klaschik E (Hrsg) Palliativmedizin. 4. Aufl. Berlin; Springer 2006: 276-279
  • 14 Bourke D L, Warley A. The steady state and breathing methods compared during morphine administration in humans.  J Physiol. 1989;  419 509-517
  • 15 Clemens K E, Klaschik E. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients.  J Pain Symptom Manage. 2007;  33 (4) 473-481
  • 16 Bouillon T, Bruhn J, Roepcke H. et al . Opioid-induced respiratory depression is associated with increased tidal volume variability.  Eur J Anaesthesiol. 2003;  20 (2) 127-133
  • 17 Argyropoulou P, Patakas D, Koukou A. et al . Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease.  Respiration. 1993;  60 (4) 216-220
  • 18 Ahmedzai S. Palliation of respiratory symptoms. In: Doyle D, Hanks GWC, MacDonald N (eds) Oxford Textbook of Palliative Medicine. 2nd. ed. Oxford; Oxford Univ Press 1998: 583-616
  • 19 Doyle D. Domicially terminal care. Edinburgh; Churchill Livingstone 1987: 33-34
  • 20 Green K, Webster H, Watanabe S. et al . Management of nosocomial respiratory tract infections in terminally ill cancer patients.  J Palliat Care. 1994;  10 (4) 31-34
  • 21 Oneschuk D, Faisinger R, Demoissac D. Antibiotic use in the last week of life in three different palliative care settings.  J Palliat Care. 2002;  18 (1) 25-28
  • 22 Pereira J, Watanabe S, Wolch G. A retrospective review of the frequency of infections and patterns of antibiotic utilization on a palliative care unit.  J Pain Symptom Manage. 1998;  16 (6) 374-381
  • 23 Vietta L, Kenner D. et al . A bacterial infection in terminally ill hospice patients.  J Pain Symptom Manage. 2000;  20 (5) 326-334
  • 24 Sorbye L W. A longitudinal study on dying in a Norwegian hospital.  Int J Palliat Nurs. 2000;  6 (2) 71-79
  • 25 Evers M M, Purohit D, Perl D. et al . Palliative and aggressive end-of-life care for patients with dementia.  Psychiatr Serv. 2002;  53 (5) 609-613
  • 26 Philip J, Gold M, Milner A. et al . A randomized, double-blind, crossover trial of the effect of oxygen on dyspnoea in patients with advanced cancer.  J Pain Symptom Manage. 2006;  32 (6) 541-550
  • 27 Higginson I J, McCarthy M. Measuring symptoms in terminal cancer: are pain and dyspnoea controlled?.  J Royal Soc Med. 1989;  82 264-267
  • 28 Wilcock A. The management of respiratory Symptoms. In: Faull C, Carter Y, Woof R (eds) Handbook of Palliative Care. Oxford; Blackwell 1998 Chapter 11: 157-176
  • 29 Driver L C, Bruera E. Dyspnea. In: Driver LC, Bruera E The M.D. Anderson Palliative Care Handbook. 2nd. ed. Houston, TX; University of Texas, M.D. Anderson Cancer Centre 2002: 71-76

Dr. med. Katri Elina Clemens

Lehr- und Forschungsstelle Universität Bonn, Zentrum für Palliativmedizin, Malteser Krankenhaus Bonn/Rhein-Sieg

Von-Hompesch-Straße 1

53123 Bonn

Email: katri-elina.clemens@malteser.de

    >